I agree. Biocells is a very good deal. I see your prespective on the 51% ownership in your other post. I can see where your coming from and believe your correct. For now its better to have this type ownership agreement with foreign entities for the valid reasons you articulated.
I'm not sure if I would agree with the strategy- of buying to profitability by years end. Its seeems this is a dangerous game.
I am curious on your thoughts. Why do you think we are purchasing these companies? Is it for the market, the assests, or the business? What do these companies have that CBAI needs, other than their inventory of stems? The companies that we bought dont have that many stems to justify the cost so I dont think that is the reason.
Do you think everthing ultimately will be stored in Nevada?
IMO, I hope CEO is spending alot of time and dilution on diversification of revenue streams. It seems there are some bigger players moving into the industry very quickly, j/j as mr long illustrated, and the recent unsolicited buyout. It would seem aquisition is going to get more expensive for quality companies. I would hope he treads carfully before moving into distressed assest purchases/agreements.
I think he has laid a good foundation and now is looking for the right partnership with enough market access and foundation to start leveraging the lab. To me this is the most direct and cost effective way to profitability.
I agree with mrl - it seems HCA could be involved.
He says hes not going to deal with Share Structure until profitability. I have no doubt he will stick with this.
When we are profitable and the true value of the company begins to emerge he said he will address SS. Which means if we think the MM's are holding the pps down he is going to have to go after them prior to correcting SS. What form do you think this will take?
What's your thoughts? Thanks.
AIMHO GLTY
News 
Market Data 
Discover 
AI
